Skip to main content
Environmental Health and Preventive Medicine logoLink to Environmental Health and Preventive Medicine
. 2016 Apr 12;21(4):215–223. doi: 10.1007/s12199-016-0525-3

Erratum to: The relationship between hypertension and health-related quality of life: adjusted by chronic pain, chronic diseases, and life habits in the general middle-aged population in Japan

Masami Kitaoka 1, Junko Mitoma 1, Hiroki Asakura 1, Olando Enoch Anyenda 1, Thao Thi Thu Nguyen 1, Toshio Hamagishi 1, Daisuke Hori 1, Fumihiko Suzuki 1, Aki Shibata 2, Masae Horii 1, Hiromasa Tsujiguchi 1, Yuri Hibino 1, Yasuhiro Kambayashi 1, Yoshiaki Hitomi 1, Naoto Shikura 1, Nakamura Hiroyuki 1,
PMCID: PMC4907935  PMID: 27072925

Erratum to: Environ Health Prev Med DOI 10.1007/s12199-016-0514-6

Unfortunately, the bold values of Tables 4, 5, 6 and 7 were published incorrectly in the original publication of the article and are corrected with this erratum.

Table 4.

Results of multiple linear regression analysis of the SF-36 scores: physical functioning (PF), role physical (RP), bodily pain (BP), and general health (GH), among men of Group 2

Explanatory variables PF RP BP GH
B (95 % CI) β B (95 % CI) β B (95 % CI) β B (95 % CI) β
Constant 106.9 (95.4, 118.4)*** 105.4 (91.6, 119.2)*** 85.1 (66.2, 104.0)*** 57.6 (43.7, 71.6)***
Age −0.189 (−0.401, 0.022) −0.108 −0.041 (−0.295, 0.213) −0.020 0.071 (−0.277, 0.418) 0.023 0.151 (−0.106, 0.407) 0.069
Obesity
 BMI <25.0a
 BMI ≥25.0 −4.89 (−8.13, −1.65) −0.170** −3.60 (−7.49, 0.286) −0.106 −5.85 (−11.2, −0.526) −0.116* 0.283 (−3.65, 4.21) 0.008
Hypertension
 Noa
 Yes 0.424 (−3.02, 3.87) 0.014 2.87 (−1.27, 7.00) 0.079 3.03 (−2.63, 8.70) 0.056 −2.71 (−6.89, 1.47) −0.071
Diabetes mellitus
 Noa
 Yes −0.429 (−5.47, 4.61) −0.009 −1.85 (−7.90, 4.20) −0.035 5.53 (−2.76, 13.8) 0.070 −10.5 (−16.6, −4.35) −0.186**
Allergic disease
 Noa
 Yes 1.88 (−3.08, 6.84) 0.043 1.60 (−4.36, 7.56) 0.031 2.60 (−5.56, 10.8) 0.033 0.864 (−5.16, 6.89) 0.016
Cancer
 Noa
 Yes −6.94 (−18.6, 4.72) −0.066 −17.9 (−31.9, −3.89) −0.145* −8.30 (−27.5, 10.9) −0.045 −17.6 (−31.8, −3.46) −0.135*
Insomnia and depression
 Noa
 Yes −7.39 (−17.2, 2.40) −0.083 −1.22 (−13.0, 10.5) −0.012 1.31 (−14.8, 17.4) 0.008 −17.8 (−29.7, −5.92) −0.162**
Chronic pain
 Noa
 Yes −5.45 (−8.73, −2.16) −0.187** −5.08 (−9.02, −1.13) −0.148* −19.6 (−25.0, −14.2) −0.385*** −6.51 (−10.5, −2.52) −0.180**
Occupational status
 Employeda
 Unemployed 0.136 (−4.12, 4.39) 0.004 −5.46 (−10.6, −0.353) −0.126* −1.06 (−8.06, 5.94) −0.016 1.06 (−4.11, 6.23) 0.023
Sleep condition
 Good sleepa
 Poor sleep −2.63 (−5.66, 0.398) −0.099 −2.52 (−6.16, 1.11) −0.080 −8.89 (−13.9, −3.91) −0.190** −6.55 (−10.2, −2.87) −0.197**
Frequency of exercise
 More than 1−2 times a weeka
 Never −3.40 (−6.42, −0.378) −0.127* −1.55 (−5.18, 2.07) −0.049 −0.877 (−5.85, 4.09) −0.019 1.13 (−2.54, 4.80) 0.034
 Number of observations 302 302 302 302
 R 2 0.132 0.103 0.238 0.174
 Adjusted R 2 0.099 0.069 0.209 0.143
 F 4.011 3.014 8.216 5.568
 Significant F 0.000 0.001 0.000 0.000

B unstandardized coefficients, β standardized coefficients

Bold values indicate p < 0.05

aReference group, * p < 0.05, ** p < 0.01, *** p < 0.001

Table 5.

Results of multiple linear regression analysis of the SF-36 scores: vitality (VT), social functioning (SF), role emotional (RE), and mental health (MH) among men of Group 2

Explanatory variables VT SF RE MH
B (95 % CI) β B (95 % CI) β B (95 % CI) β B (95 % CI) β
Constant 43.6 (27.5, 59.7)*** 99.9 (85.4, 114.5)*** 107.5 (93.1, 121.9)*** 59.3 (44.8, 73.7)***
Age 0.578 (0.282, 0.874) 0.222*** 0.029 (−0.238, 0.297) 0.013 −0.022 (−0.286, 0.242) −0.010 0.381 (0.115, 0.647) 0.174**
Obesity
 BMI <25.0a
 BMI ≥25.0 −0.809 (−5.34, 3.72) −0.019 −4.37 (−8.47, −0.277) −0.123* −4.35 (−8.39, −0.315) −0.124* 0.768 (−3.30, 4.84) 0.021
Hypertension
 Noa
 Yes 4.19 (−0.627, 9.01) 0.092 5.66 (1.30, 10.0) 0.149* 4.09 (−0.207, 8.39) 0.109 3.11 (−1.22, 7.44) 0.081
Diabetes mellitus
 Noa
 Yes −0.463 (−7.51, 6.59) −0.007 0.238 (−6.14, 6.61) 0.004 −2.46 (−8.75, 3.83) −0.045 −1.39 (−7.73, 4.95) −0.025
Allergic disease
 Noa
 Yes 3.10 (−3.84, 10.0) 0.047 4.85 (−1.43, 11.1) 0.089 0.977 (−5.22, 7.17) 0.018 0.754 (−5.49, 7.00) 0.014
Cancer
 Noa
 Yes −15.8 (−32.1, 0.494) −0.102 0.641 (−14.1, 15.4) 0.005 −6.12 (−20.7, 8.42) −0.048 −5.93 (−20.6, 8.73) −0.046
Insomnia and depression
 Noa
 Yes −9.66 (−23.4, 4.04) −0.074 −10.0 (−22.4, 2.35) −0.092 −2.32 (−14.5, 9.90) −0.022 −7.83 (−20.1, 4.49) −0.071
Chronic pain
 Noa
 Yes −9.93 (−14.5, −5.34) −0.231*** −1.22 (−5.38, 2.94) −0.034 −3.70 (−7.80, 0.40) −0.104 −5.53 (−9.66, −1.40) −0.153**
Occupational status
 Employeda
 Unemployed 0.025 (−5.93, 5.98) 0.000 −5.63 (−11.0, −0.244) −0.124* −7.79 (−13.1, −2.48) −0.174** −1.01 (−6.36, 4.35) −0.022
Sleep condition
 Good sleepa
 Poor sleep −7.72 (−12.0, −3.48) −0.195*** −3.26 (−7.10, 0.568) −0.099 −2.36 (−6.14, 1.42) −0.072 −4.87 (−8.68, −1.06) −0.146*
Frequency of exercise
 More than 1−2 times a weeka
 Never −5.33 (−9.55, −1.10) −0.134* −4.14 (−7.96, −0.313) −0.125* −2.74 (−6.51, 1.04) −0.084 −2.81 (−6.62, 0.988) −0.084
 Number of observations 302 302 302 302
 R 2 0.227 0.094 0.092 0.117
 Adjusted R 2 0.198 0.060 0.058 0.083
 F 7.748 2.741 2.674 3.486
 Significant F 0.000 0.002 0.003 0.000

B unstandardized coefficients, β standardized coefficients

Bold values indicate p < 0.05

aReference group, * p < 0.05, ** p < 0.01, *** p < 0.001

Table 6.

Results of multiple linear regression analysis of the SF-36 scores: physical functioning (PF), role physical (RP), bodily pain (BP), and general health (GH), among women of Group 2

Explanatory variables PF RP BP GH
B (95 % CI) β B (95 % CI) β B (95 % CI) β B (95 % CI) β
Constant 96.5 (87.4, 105.5)*** 96.5 (84.2, 108.8)*** 77.1 (61.4, 92.7)*** 62.3 (49.1, 75.6)***
Age 0.040 (−0.129, 0.208) 0.026 0.099 (−0.129, 0.327) 0.049 0.224 (−0.066, 0.513) 0.079 0.295 (0.049, 0.541) 0.128*
Obesity
 BMI <25.0a
 BMI ≥25.0 −1.14 (−4.27, 1.99) −0.038 −3.23 (−7.46, 1.01) −0.080 1.73 (−3.66, 7.12) 0.030 −1.54 (−6.11, 3.04) −0.033
Hypertension
 Noa
 Yes −2.57 (−5.65, 0.505) −0.090 1.81 (−2.36, 5.97) 0.047 −3.77 (−9.07, 1.52) −0.069 −8.84 (−13.3, −4.34) −0.200***
Diabetes mellitus
 Noa
 Yes 3.87 (−1.89, 9.63) 0.070 1.39 (−6.40, 9.19) 0.019 1.51 (−8.40, 11.4) 0.014 −8.12 (−16.5, 0.312) −0.096
Allergic disease
 Noa
 Yes −0.991 (−4.13, 2.15) −0.033 0.665 (−3.58, 4.91) 0.016 0.624 (−4.77, 6.02) 0.011 −0.615 (−5.20, 3.97) −0.013
Cancer
 Noa
 Yes −8.72 (−15.9, −1.57) −0.127* −5.12 (−14.8, 4.55) −0.055 −3.32 (−15.6, 8.99) −0.025 −1.24 (−11.7, 9.22) −0.012
Insomnia and depression
 Noa
 Yes −11.1 (−19.1, −3.22) −0.145** −14.7 (−25.4, −4.00) −0.142** −9.97 (−23.6, 3.65) −0.068 −14.6 (−26.2, −3.04) −0.124*
Chronic pain
 Noa
 Yes −1.48 (−4.12, 1.16) −0.058 −2.07 (−5.63, 1.50) −0.060 −22.6 (−27.2, −18.1) −0.469*** 5.72 (−9.58, −1.86) −0.146**
Occupational status
 Employeda
 Unemployed −2.91 (−5.77, −0.054) −0.109* −4.19 (−8.06, −0.323) −0.117* −2.14 (−7.06, 2.78) −0.042 −5.28 (−9.46, −1.10) −0.129*
Sleep condition
 Good sleepa
 Poor sleep −3.13 (−5.53, −0.732) −0.136* −6.32 (−9.56, −3.07) −0.203*** −4.41 (−8.53, −0.280) −0.101* −8.77 (−12.3, −5.26) −0.247***
Frequency of exercise
 More than 1−2 times a weeka
 Never −2.36 (−4.77, 0.061) −0.101 −0.520 (−3.79, 2.75) −0.017 −0.626 (−4.78, 3.53) −0.014 −0.970 (−4.50, 2.57) −0.027
 Number of observations 348 348 348 348
 R 2 0.100 0.094 0.261 0.189
 Adjusted R 2 0.071 0.065 0.236 0.162
 F 3.411 3.180 10.76 7.102
 Significant F 0.000 0.000 0.000 0.000

B unstandardized coefficients, β standardized coefficients

Bold values indicate p < 0.05

aReference group, * p < 0.05, ** p < 0.01, *** p < 0.001

Table 7.

Results of multiple linear regression analysis of the SF-36 scores: vitality (VT), social functioning (SF), role emotional (RE), and mental health (MH) among women of Group 2

Explanatory variables VT SF RE MH
B (95 % CI) β B (95 % CI) β B (95 % CI) β B (95 % CI) β
Constant 35.1 (20.6, 49.6)*** 78.8 (65.3, 92.4)*** 85.4 (72.7, 98.1)*** 51.2 (37.9, 64.5)***
Age 0.718 (0.450, 0.987) 0.279*** 0.275 (0.023, 0.526) 0.124* 0.269 (0.034, 0.504) 0.126* 0.532 (0.286, 0.778) 0.231**
Obesity
 BMI <25.0a
 BMI ≥25.0 2.81 (−2.19, 7.81) 0.054 1.99 (−2.69, 6.66) 0.045 −3.03 (−7.39, 1.34) −0.071 3.31 (−1.26, 7.89) 0.072
Hypertension
 Noa
 Yes −4.69 (−9.61, 0.226) −0.095 −1.96 (−6.56, 2.63) −0.046 1.46 (−2.83, 5.75) 0.036 −2.77 (−7.27, 1.73) −0.063
Diabetes mellitus
 Noa
 Yes 3.37 (−5.83, 12.6) 0.036 7.04 (−1.57, 15.6) 0.087 −0.798 (−8.84, 7.24) −0.010 −0.440 (−8.86, 7.98) −0.005
Allergic disease
 Noa
 Yes −1.15 (−6.16, 3.86) −0.022 −0.580 (−5.26, 4.10) −0.013 0.181 (−4.19, 4.56) 0.004 1.83 (−2.75, 6.42) 0.039
Cancer
 Noa
 Yes −1.11 (−12.5, 10.3) −0.009 −0.546 (−11.2, 10.1) −0.005 −3.63 (−13.6, 6.35) −0.037 −0.808 (−11.3, 9.64) −0.008
Insomnia and depression
 Noa
 Yes −14.0 (−26.6, −1.32) −0.106* −4.91 (−16.7, 6.91) −0.043 −15.9 (−27.0, −4.89) −0.146** −17.8 (−29.4, −6.26) −0.152**
Chronic pain
 Noa
 Yes −10.0 (−14.2, −5.81) −0.229*** −2.95 (−6.88, 0.991) −0.079 −2.69 (−6.37, 0.985) −0.075 −2.32 (−6.17, 1.53) −0.060
Occupational status
 Employeda
 Unemployed 0.115 (−4.45, 4.68) 0.003 −0.875 (−5.15, 3.40) −0.022 −3.02 (−7.01, 0.973) −0.080 0.274 (−3.91, 4.45) 0.007
Sleep condition
 Good sleepa
 Poor sleep −9.46 (−13.3, −5.63) −0.239*** −6.55 (−10.1, −2.97) −0.193*** −9.18 (−12.5, −5.83) −0.280*** −11.3 (−14.9, −7.84) −0.321***
Frequency of exercise
 More than 1−2 times a weeka
 Never −3.21 (−7.07, 0.654) −0.080 1.47 (−2.14, 5.08) 0.043 1.06 (−2.31, 4.43) 0.032 −0.639 (−4.17, 2.89) −0.018
 Number of observations 348 348 348 348
 R 2 0.222 0.074 0.130 0.180
Adjusted R2 0.197 0.043 0.102 0.153
 F 8.736 2.429 4.569 6.702
 Significant F 0.000 0.006 0.000 0.000

B unstandardized coefficients, β standardized coefficients

Bold values indicate p < 0.05

aReference group, * p < 0.05, ** p < 0.01, *** p < 0.001

The standardized coefficients “β” values which contain asterisks (*, ** and ***) should be in bold.

Footnotes

The online version of the original article can be found under doi:10.1007/s12199-016-0514-6.


Articles from Environmental Health and Preventive Medicine are provided here courtesy of The Japanese Society for Hygiene

RESOURCES